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ABSTRACT 
Objectives: The aim of the present study was to isolate, identify and analyze the phylogenetic characteristics of the potent actinobacterial strain 
VJDS-1 with antagonistic activities isolated from Mangrove ecosystems of Nizampatnam, Guntur Dist, A.P., India.  
Methods: Soil samples collected were pre treated with calcium carbonate and used for isolation of potent actinobacterial strain designated as VJDS-
1. Identification of the strain was carried out by studying the micro morphological, cultural, biochemical and physiological methods. The 
Phylogenetic study of the strain was carried out by employing 16S rDNA sequence based analysis. Phylogenetic tree was constructed using the 
MEGA (Molecular Evolutionary Genetic Analysis) software version 6.  
Results: The potent actinobacterial strain was identified as Streptomyces cellulosae VJDS-1 and the bioactive metabolites produced by the strain 
inhibited Gram positive bacteria (Staphylococcus aureus, Bacillus megaterium), Gram negative bacteria (Xanthomonas campestris, Proteus vulgaris, 
Pseudomonas aeruginosa and Escherichia coli) and fungi (Aspergillus niger, Botrytis cinerea, Fusarium solani F. oxysporum and Candida albicans). 
Conclusion: The results of the experiment showed that the crude ethyl acetate extract of Streptomyces cellulosae VJDS-1 showed significant 
antimicrobial potential hence it can be used for isolation of compounds with pharmaceutical importance. 
Keywords: Mangrove ecosystems, Phylogenetic study, Streptomyces cellulosae, Bioactive compounds. 
 
INTRODUCTION 
Marine bacteria produce unique and novel secondary metabolites 
with interesting biological activities. Among different types of 
marine bacteria, actinomycetes play an extensive role in the 
pharmaceutical and medical industry for their capacity to produce 
secondary metabolites with diverse chemical structures and 
biological activities. Thousands of bioactive compounds have been 
isolated and characterized, many of which have been developed into 
drugs for treatment of wide range of diseases in human, veterinary 
and agriculture sectors [1]. The salinity, low temperature, pressure 
and stress conditions in marine environments provoke a set of 
different metabolic pathways and defense systems compared to 
their terrestrial counterparts, ensuring the potential ability to 
produce novel antibiotics. 
The genus Streptomyces consists of 640 species with validly 
published names [2]. Since the discovery of streptomycin, various 
pharmaceutically important drugs have been discovered from the 
genus Streptomyces [3-6] and exploration of the natural 
environment with the aim of discovering novel species of this genus 
is important. In addition, characterization of the physiological and 
genotypic features of members of this genus will broaden the 
understanding of the behavior of these organisms in various 
ecosystems.  
The complex metabolic machinery of Streptomycetes can produce an 
infinite variety of secondary metabolites, including dark-brown to 
black melanoid pigments that play important ecological roles in the 
environment [7, 8]. The competitive superiority of some 
Streptomyces species in the rhizosphere protects plants against root 
pathogens [9, 10], which could be important in the early stages of 
plant establishment [11].  
As part of our ongoing screening of different habitats of our near 
marine ecosystems of Guntur district resulted in the isolation of a 
potent strain VJDS-1 with a broad spectrum activity against different 
Gram positive and Gram negative bacteria as well as fungi. An 
attempt was made in the present study to identify the strain based 
on the polyphasic taxonomic approach along with its antimicrobial 
profile. 
MATERIALS AND METHODS 
Sample collection 
Soil samples were randomly collected from mangrove ecosystem of 
Nizampatnam, Guntur distrist, south coast of Andhra Pradesh, India. 
They were brought to the laboratory in sterilized containers and air 
dried for 2-5 days at room temperature (30±2 °C). The air dried soil 
samples were pre treated with CaC03
Isolation 
 (10:1w/w) and incubated at 
30 °C for four days [12]. 
Dilution plate technique was employed for isolation of 
actinobacteria by employing humic acid vitamin (HV) agar medium 
[13]. The medium was adjusted to pH 7.0 and 0.1 mL of diluted soil 
sample spread over HV agar supplemented with 25 μg/ml Nystatin 
and 25 μg/ml Streptomycin to reduce the fungal and bacterial 
contamination respectively and incubated at 30±2o
Identification of the potent strain VJDS-1 by polyphasic 
approach 
C for 7 days. 
Actinobacterial colonies [14] were picked out, purified and 
preserved on YMD (yeast extract malt extract dextrose) agar slants 
at 4 °C [15]. The actinobacterial strains were then screened for their 
potential to generate bioactive compounds [16]. Among the 20 
isolates tested for biological activity, one isolate designated as VJDS-
1 was found to be potent as it exhibited high antimicrobial activity. 
Morphological, Cultural, Physiological and biochemical 
characteristics of the strain 
The potent actinobacterial strain was characterized by cultural, 
morphological, physiological, biochemical and molecular methods. 
The microscopic characterization was carried out by slide culture 
method [17] taking into account the nature of mycelium, color and 
spore arrangement [18]. The morphological characteristics were 
assessed using scanning electron microscopy (SEM: Model-JOELJSM 
5600, Japan) of 4-day old culture grown on yeast extract malt extract 
dextrose agar (YMD) medium at various magnifications. The strain 
was grown on seven International Streptomyces Project (ISP) media 
and four non-ISP media to observe the cultural characteristics such 
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as color of aerial mycelium, substrate mycelium, pigment production 
and spore formation [19]. Melanin pigment production was assessed 
by culturing the strain on tyrosine agar (ISP-7) medium [20]. 
Hydrolysis of starch and nitrate reduction [21] and H2
Molecular identification 
S production 
were also tested [22]. Physiological characteristics such as the effect 
of pH (5-9), temperature (20-45 °C) and salinity on the growth of the 
strain analyzed. The susceptibility of the strain to different 
antibiotics was also determined by paper disc method [23]. 
The genomic DNA used for the PCR (Polymerase Chain Reaction) 
was prepared from the colonies grown on YMD agar for 3 days. The 
total genomic DNA extracted from the strain was isolated by 
employing the DNA purification Kit (Pure Fast® Bacterial Genomic 
DNA purification kit, Helini Bio molecules, India) according to the 
manufacturer protocol. The 16S rRNA gene fragment was amplified 
using Actino specific forward Primer-5'-
GCCTAACACATGCAAGTCGA-3' and actino specific reverse primer-5'-
CGTATTACCGCGGCTGCTGG-3'. Conditions of the PCR were 
standardized with initial denaturation at 94 °C for 3 min followed by 
30 cycles of amplification (Denaturation at 94 °C for 60 sec, 
annealing temperature of 55 °C for 60 sec and extension at 72 °C for 
60 sec) and an addition of 5 min at 72 °C as final extension. The 
amplification reactions were carried with a total volume of 50 µl in a 
Gradient PCR (Eppendorf, Germany). Each reaction mixture 
contained 1 µl of DNA, 1 µl of 10 p mol forward 16S Actino specific 
primer (5´-AAATGGAGGAAGGTGGGGAT-`3), 1 µl of 10 pmol reverse 
16S Actino specific primer (5´-AGGAGGTGATCCAACCGCA-`3), 25 µl 
of Master Mix and 22 µl of molecular grade nuclease free water. The 
separation was carried out at 90 Volts for 40 min in TAE buffer with 
5 µl of Ethidium bromide. PCR product was analyzed using 1 % 
agarose gel and the fragment was purified (Helini Pure Fast PCR 
clean up kit, Helini Bio molecules, India) as per the manufacturer’s 
instructions. The bands were analyzed under UV light and 
documented using Gel Doc. The direct sequencing of PCR products 
was performed by dideoxy chain termination method using 3100-
Avant Genetic Analyzer (Applied Bio systems, USA). The sequences 
thus obtained were analyzed for homology using BLASTN (Entrez 
Nucleotide database). The deduced 16s rDNA sequence was 
compared with the sequences in GenBank (http://www. ncbi. nlm. 
nih. gov/) using the Basic Local Alignment Search Tool (BLAST) then 
aligned with the related reference sequences retrieved from 
GenBank databases using the Clustal W method. Phylogenetic and 
molecular evolutionary analyses were conducted using MEGA 
(Melecular Evolutionary Genetic Analysis) version 6.0 [24]. 
Nucleotide sequence accession numbers 
The 16S rRNA gene (rDNA) sequence of the strain VJDS-1 is 
registered in the Gen Bank database. 
Growth pattern of the strain VJDS-1 
To determine the growth pattern, the strain was inoculated into 250 
ml flasks containing 100 ml YMD broth and incubated at 30±2 °C on 
a rotary shaker at 180 rpm. The flasks were harvested at 24 h 
interval and the growth of the strain was determined by taking the 
dry weight of biomass. The culture filtrates obtained after separating 
the biomass were extracted with ethyl acetate and antimicrobial 
activity of crude extract was determined by agar well diffusion 
method. 
Extraction of metabolites and antimicrobial assay 
The antimicrobial activity of the strain was determined by agar well 
diffusion assay. The homogenous culture suspension prepared by 
suspending three day old culture in sterile saline was used to 
inoculate YMD broth (seed medium) and the culture was incubated 
at 30 °C for 48 h on a rotator shaker at 180 rpm. Seed culture at the 
rate of 10 % was transferred to YMD broth (Fermentation medium). 
The fermentation was carried out at 30±2 °C for 120 h under 
agitation at 180 rpm. Antimicrobial compound was recovered from 
the filtrate by solvent extraction method. Ethyl acetate was added to 
the filtrate (1:1) and shaken vigorously. The ethyl acetate extract 
was evaporated to dryness in the water bath and the residue thus 
obtained was used to determine antimicrobial activity. Ethyl acetate 
itself was used as negative control. 80μl of the crude extract and 
80μl of negative control were poured in to separate wells. The 
standard antibiotic disc was placed on the agar surface as positive 
control. For each bacterial strain, controls were maintained utilizing 
pure solvent. Plates were incubated at 37 °C for 48 h and inhibition 
zones (in mm) were measured after 24-48 h. Experiment was 
carried out in triplicates for each test organism and the mean values 
were computed. 
Test organisms 
Bacteria: Staphylococcus aureus (MTCC 3160), Lactobacillus casei, 
Bacillus megaterium (NCIM 2187), Xanthomonas campestris (MTCC 
2286), Proteus vulgaris (ATCC 6380), Pseudomonas aeruginosa 
(ATCC 9027), Salmonella entericus and Escherichia coli (ATCC 9027). 
Fungi: Aspergillus niger, Botrytis cinerea, Fusarium solani F. 
oxysporum and Candida albicans (MTCC 183).  
RESULTS AND DISCUSSION  
A total of 20 actinobacterial strains were isolated from the 
mangrove ecosystem of Nizampatnam designated as VJDS-1 to VJDS-
20. Among the 20 strains, one actinobacterial strain VJDS-1 was 
found to be potent and exhibited strong antimicrobial activity 
against Gram positive and Gram negative bacteria. The strain VJDS-1 
exhibited typical morphological characteristics of the genus 
Streptomyces. Morphological and micro morphological observation 
of the strain was studied by SEM and revealed that the strain 
exhibited heavy sporulation with spiral arrangement and the surface 
of the spore was rough (fig. 1). 
 
 
Fig. 1: Scanning electron microscopic photograph of 
Streptomyces cellulosae VJDS-1 
 
Cultural characteristics 
The cultural characteristics of the strain are represented in table 1. 
The strain VJDS-1 exhibited good growth on Tryptone yeast extract 
agar (ISP-1), YMD agar (ISP-2), Glycerol asparagine agar (ISP-5) and 
Glucose tryptone agar (Non ISP). The growth was moderate on 
Nutrient agar (Non ISP) and Starch casein salts agar (Non ISP). The 
colour of aerial mycelium was white and substrate mycelium was 
pale brown on the different media tested. Soluble pigment 
production was not observed on the media tested.  
Biochemical and physiological characteristics of the strain 
VJDS-1 
The physiological tests are significant tools for classification and 
identification of Actinobacteria and influencing the growth rate of 
Actinobacteria [20-22]. Details of biochemical and physiological 
characteristics of the strain are given in table 2. The strain VJDS-1 
exhibited the positive response. 
To catalase production, H2S production and citrate utilization. 
Growth of the strain VJDS-1 occurred in the pH range of 5-10 with 
optimum growth at pH 7 and the range of temperature for growth, 
was 25-55 °C with the optimum being 30 °C. Sodium chloride 
tolerance of the strain was also studied as the salt concentration has 
a profound effect on the production of antibiotics from 
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microorganisms. The strain could grow well in the medium 
supplemented with 3% sodium chloride and shown tolerance upto 
9%. Though the strain utilized a wide range of carbon sources, the 
growth was good when supplemented with glucose. The strain was 
resistant to the majority of antibiotics tested and showed sensitivity 
to gentamicin, kanamycin and ciprofloxacin. 
 
Table 1: Cultural characteristics of the strain VJDS-1 
Name of the medium Growth AM* SM** Pigmentation 
Tryptone yeast-extract agar (ISP-1) Good White Pale Brown No 
Yeast extract malt extract dextrose agar (ISP-2) Good White Pale Brown No 
Oat-meal agar (ISP-3) Poor White Pale Brown No 
Inorganic salts Starch Agar (ISP-4) Poor White Pale Brown No 
Glycerol Asparagine agar (ISP-5) Good White Pale Brown No 
Tyrosine agar (ISP-7) Poor White Pale Brown No 
Czapek-Dox agar Poor White Pale Brown No 
Nutrient agar Moderate White Pale Brown No 
Bennets agar Poor White  Pale Brown No 
Starch casein salts agar Moderate White  Pale Brown No 
Glucose tryptone agar Good White Pale brown No 
*Aerial mycelium **Substrate mycelium 
 
Table 2: Morphological, biochemical and physiological characteristics of the strain VJDS-1 
Character  Response 
Morphological characters 
Sporophore morphology  Rectiflexible  
Color of aerial mycelium  White  
Color of substrate mycelium  Pale yellow to brown 
Biochemical characters 
Catalase production  - 
Urease production  - 
Hydrogensulfide production test + 
Nitrate reduction  - 
Starch hydrolysis  + 
Gelatin liquefaction  - 
Methyl red test  - 
Voges proskauer test  - 
Indole production  - 
Citrate utilization  + 
 Physiological characters 
Gram reaction  + 
Production of melanin pigment  - 
Range of temperature for growth  25-55 °C  
Optimum temperature for growth  30 °C 
Range of pH for growth  5-10 
Optimum pH for growth  7 
NaCl tolerance  Up to 9% 
Utilization of carbon sources (w/v)*  
Lactose - 
Maltose - 









Antibiotic sensitivity  
Gentamicin (10µg) S 
Kanamycin (10µg) S 
Penicillin (10µg) R 
Co-trimoxazole (25µg)  R 
Ciprofloxacin (10µg) S 
Erythromycin (10 µg R 
Lincomycin (10µg) R 
Cefuraxime (30µg) R 
* Growth of the strain measured as dry weight of the mycelium ‘+++’-good growth; ‘++’-moderate growth; ‘+’-weak growth; ‘-‘indicates negative/no 
growth; S–Sensitive; R–Resistant; P–Positive; N–Negative. 
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Molecular characterization 
Analysis of the 16S rDNA gene sequence of the strain VJDS-1 
The 16S rDNA sequence data supported the assignment of the strain 
VJDS-1 to the genus Streptomyces and species cellulosae. The partial 
16S rDNA sequence of the strain VJDS-1 was submitted to the 
GenBank database under an accession number KP170478. The 
partial sequence was aligned and compared with all the 16S rDNA 
gene sequence available in the GenBank database by using the multi 
sequence advanced BLAST comparison tool.  
The phylogenetic analysis of the 16S rRNA gene sequence was 
aligned using the CLUSTAL W programme from the MEGA 5 Version. 
Phylogenetic tree (Fig-2) was constructed using MEGA software 
Version 5 using Neighbor-joining method. The topology of the 
constructed tree was evaluated by bootstrap analysis with 1000 re 
samplings by Maximum parsimony tool. 
  
 
Fig. 2: Neighbor-Joining tree based on partial 16S rRNA gene sequence showing relationship between Streptomyces strain VJDS-1 and 
related members of the genus Streptomyces 
 
Growth Pattern and antimicrobial profile of Streptomyces 
cellulosae VJDS-1 
The growth pattern of Streptomyces cellulosae was studied on YMD 
broth. The stationary phase of the strain extended from 120 hr to 
144 h of incubation. The bioactive metabolites obtained from 5-day-
old culture exhibited high antimicrobial activity against the test 
microorganisms (fig. 3). Naragani et al. (2014) reported that 
metabolites obtained from five day old culture of Rhodococcus 
erythropolis VLK-12 showed maximum antimicrobial activity [25]. 
Narayana et al. (2004) showed that Streptomyces sp. isolated from 
virgin soil elaborated maximum antimicrobial metabolites 
production after 120 h. Narayana et al. (2007) stated that 
Streptomyces albidoflavus elaborated maximum antimicrobial 
metabolites production after 120 h.  
 
 
Fig. 3: Growth pattern of the strain Streptomyces cellulosae 
VJDS-1 
 
The secondary metabolites obtained from four-day old culture of 
Nocardia levis MK-VL_113 [26], Streptomyces tendae TK-VL_333 
[27], S. cheonanensis VUK-A [28] showed high antimicrobial activity 
against the test microbes. The antimicrobial spectrum of the strain 
cultured on YMD broth for five days was shown in table 3.  
The metabolites extracted from the five day old culture broth 
showed maximum activity against Proteus vulgaris, Bacillus 
megaterium and Xanthomonas campestris. In case of fungi Candida 
albicans showed maximum sensitivity when compared to the other 
fungi tested. 
 
Table 3: Antibacterial and antifungal activity of Streptomyces 
cellulosae VJDS-1 




 Bacteria:     
Staphylococcus aureus 20±0.15 22±0.05 
Lactobacillus casei 20±0.08 28±0.10 
Xanthomonas campestris 22±0.12 25±0.12 
Bacillus megaterium 24±0.14 25±0.08 
Escherichia coli 16±0.09 20±0.05 
Pseudomonas aeruginosa 18±0.11 22±0.15 
Salmonella entericus 10±0.14 15±0.12 
Proteus vulgaris 26±0.11 28±0.08 
Fungi:     
Aspergillus niger 16±0.05 20±0.05 
Botrytis cinerea 15±0.08 28±0.08 
Fusarium solani 16±0.12 21±0.05 
F. oxysporum 15±0.12 18±0.12 
Candida albicans 27±0.05 30±0.05 
#Positive control: Tetracycline against bacteria, Griseofulvin against 
yeast and Carbendazim against fungi, Values are mean±S. E. M (n = 
3), Mean percent inhibition on bacteria: 84.3%, Mean percent 
inhibition on fungi: 76.0%. 
Muvva et al. 
Int J Pharm Pharm Sci, Vol 7, Issue 7, 57-61 
61 
CONCLUSION 
The present investigation highlights the antimicrobial potential of 
Streptomyces cellulosae VJDS-1. The results state important evidence 
of use of crude ethyl acetate extract for isolation of antimicrobial 
compounds. Further study on optimization, purification and 
chemical characterization of bioactive compounds of the strain are 
in progress. 
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